Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taicang Xintai Alcohol is a China-based manufacturer of ethanol and related alcohol products, including medicinal alcohol, edible alcohol, anhydrous ethanol, denatured alcohol, disinfectants, hand sanitizers, liquid carbon dioxide, and dry ice. The company appears to operate primarily as an industrial and commercial producer rather than as a drug developer, with products supplied into pharmaceutical, food, electronics, cosmetics, fine chemical, and consumer goods markets. Publicly available information indicates that it is a wholly owned subsidiary of a Singapore parent and operates manufacturing facilities in the Taicang Port development zone in Jiangsu. In healthcare, its relevance is mainly through supply of pharmaceutical-grade ethanol and related materials rather than through a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taicang Xintai Alcohol.